RCOG World Congress 2023

STUDY OF HYPERTENSIVE DISORDERS OF PREGNANCY IN CORRELATION WITH GESTOSIS SCORE

INTRODUCTION

Hypertension during pregnancy is a major health problem. Hypertensive disorder of Pregnancy (Gestational

Hypertension (GHT), Pre-eclampsia (PE) & Eclampsia (E) occurs in approximately 6-8 % of all pregnancies [1].

It accounts for approximately a quarter of all antenatal admissions [2]. Favourable maternal and perinatal outcomes for

women with preeclampsia/eclampsia depend on how soon the condition is identified and how quickly the woman has

access to treatment [3]. Four potentially useful biomarkers at 11–13 weeks’gestation as a screening tool for

preeclampsia are mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum pregnancy-associated

plasma protein-A (PAPP-A), and serum placental growth factor (PlGF)[4]. Abnormal uteroplacental circulation

could be observed as abnormal Doppler in the uterine arteries by ultrasound (increased UtA-PI) from as early as

the first trimester of pregnancy.

The traditional approach for the identification of high-risk women for Preeclampsia follows the recommendations

of organizations, such as National Institute for Health and Care Excellence (NICE) and American College of

Obstetricians and Gynaecologists (ACOG). Screening as per nice guidelines includes identifying risk factors from

maternal demographic characteristics and medical history [5]

HDP Gestosis score is a newer modality of screening for preeclampsia. Score 1, 2, 3 has been given to each clinical

risk factors as per its severity of development. Mild risk factor has allotted a score of 1, 2 to moderate and 3 to high

risk factor.When total score is >/=3, pregnant women should be marked as “AT RISK FOR HDP” [6].

In present study, we aimed to investigate the correlation of Gestosis score with development of preeclampsia and

the overall predictive performance of the score.

STUDY OF HYPERTENSIVE DISORDERS OF PREGNANCY IN CORRELATION WITH GESTOSIS SCORE